BL vs DBD

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 16, 2026

BL

48.4
AI Score
VS
DBD Wins

DBD

70.3
AI Score

Investment Advisor Scores

BL

48score
Recommendation
HOLD

DBD

70score
Recommendation
BUY

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric BL DBD Winner
Revenue 370.98M 1.82B DBD
Net Income 24.61M 20.50M BL
Gross Margin 76.0% 24.8% BL
Net Margin 6.6% 1.1% BL
Operating Income 17.23M 90.00M DBD
ROE 7.8% 2.1% BL
ROA 1.7% 0.5% BL
Total Assets 1.47B 3.74B DBD
Current Ratio 1.72 1.27 BL

Relative Price Performance (Last 90 Days)

BL 1M: +16.0% · 3M: +10.0% DBD 1M: -19.6% · 3M: -3.4%

Current Technical Phase

BL

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.0% over 20 days), RSI 57

RSI (14): 56.8 · Price: $31.83

DBD

Markdown
Sell / avoid

Price below a falling SMA50 (slope -1.4%), weak momentum, RSI 39

RSI (14): 38.7 · Price: $69.94

Fundamentals Snapshot

Metric BL DBD
Market Cap
Forward P/E 11.5 10.0
Trailing P/E 57.0 22.3
Revenue (TTM)
Revenue Growth 0.1% 0.0%
Gross Margin 0.8% 0.3%
Operating Margin 0.1% 0.1%
EPS 0.56 3.04
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, DBD is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.